The use of advanced biological and tissue-engineered wound products
Art & Science Previous     Next

The use of advanced biological and tissue-engineered wound products

Mark Collier Lead nurse consultant in tissue viability, United Lincolnshire Hospitals NHS Trust, Boston, Lincolnshire

This article aims to reintroduce readers to biologically based and tissue-engineered wound management products. Indications for their use in clinical practice are suggested. It also examines two well-established wound management interventions, topical negative pressure therapy and larval therapy, which could have a positive effect on the outcome of biologically based and tissue-engineered wound management products.

Nursing Standard. 21, 7,68-76. doi: 10.7748/ns2006.10.21.7.68.c6364

Correspondence

mark.collier@ulh.nhs.uk

Peer review

This article has been subject to double blind peer review